Entities, complications, and primary source of infection (n = 187) | Gram-positive bacteria (n = 162, 86.6%) | Gram-negative bacteria (n = 25, 13.4%) | p-value* |
---|---|---|---|
SD | 105/162 (64.8%) | 20/25 (80.0%) | 0.172 |
ISEE | 57/162 (35.2%) | 5/25 (20.0%) | |
Sepsis | 81/162 (50.0%) | 13/25 (52.0%) | 1.0 |
Septic embolism | 46/128 (35.9%) | 4/22 (18.2%) | 0.142 |
Endocarditis | 23/139 (16.5%) | 0/22 (0.0%) | 0.046 |
Relapse rate | 22/103 (21.4%) | 6/20 (30.0%) | 0.394 |
Disease-related mortality | 9 (5.6%) | 1 (4.0%) | 1.0 |
Source of infection (129/187, 69.0%) | |||
Hematogenous spread | < 0.001(1) | ||
Gastrointestinal tract infection | 6/107 (5.6%) | 3/22 (13.6) | |
Respiratory tract infection (pneumonia) | 15/107 (14.0%) | 1/22 (4.5%) | |
Urinary tract infection (urosepsis) | 4/107 (3.7%) | 9/22 (40.9%) | |
Skin infection | 34/107 (31.8%) | 3/22 (13.6%) | |
Foreign body-associated infection (joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine) | 20/108 (18.7%) | 3/22 (13.6%) | |
Odontogenic infection | 5/107 (4.7%) | 0/22 (0.0%) | |
Retropharyngeal & prevertebral infection | 4/107 (3.7) | 2/22 (9.1%) | |
Post-interventional | |||
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia | 19/107 (17.8%) | 1/22 (4.5%) |